Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 7 de 7
1.
Future Microbiol ; 18: 1137-1146, 2023 Nov.
Article En | MEDLINE | ID: mdl-37830930

Aim: This study evaluated the antifungal efficacy of gentian violet (GV) in an experimental vulvovaginal candidiasis (VVC) model. Materials & methods: In vitro susceptibility and cytotoxicity assays were performed to validate the antifungal potential and safety of GV. The antifungal efficacy was then evaluated in vivo through comparative analysis of the fungal burden following treatment with GV or nystatin, as well as assessment of the vaginal tissue by histology and electron microscopy. Results: GV demonstrated a safe antifungal profile against C. albicans, with a significant decrease in fungal burden and an improvement in the inflammatory process evaluated histologically. Conclusion: The results of this study motivate further assessment of GV as a promising alternative for VVC therapy.


Candidiasis, Vulvovaginal , Female , Humans , Mice , Animals , Candidiasis, Vulvovaginal/drug therapy , Candidiasis, Vulvovaginal/microbiology , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Gentian Violet/therapeutic use , Candida albicans , Nystatin/pharmacology , Nystatin/therapeutic use
3.
Microbiol Res ; 258: 126996, 2022 May.
Article En | MEDLINE | ID: mdl-35247799

Candida albicans is a commensal microorganism of the human microbiota that can be associated with superficial to disseminated infections. This species possesses several attributes that contribute to pathogenesis and virulence, such as the ability to transition from yeast to hyphae forms. During this transition, several changes occur in the fungal cell wall, which is the first point of contact between the pathogen and the host. The cell wall is a bi-layered structure, containing chitin, glucan, and proteins, the latter of which play important roles in pathogenesis. Given the importance of this structure, particularly in filamentation, this review focuses on the studies of C. albicans mutants for genes that encode cell wall-associated proteins that have an important role in the virulence, and also have a role in hyphal morphogenesis. Thus, we highlight some proteins whose mutation is associated with attenuated virulence in vivo and have defective filamentation. We also provide examples of proteins whose inactivation does not impair the filamentation yet are still important for C. albicans virulence.


Candida albicans , Candidiasis , Candida albicans/metabolism , Candidiasis/microbiology , Cell Wall/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Humans , Hyphae/genetics , Hyphae/metabolism , Virulence
4.
Future Microbiol ; 16: 211-219, 2021 03.
Article En | MEDLINE | ID: mdl-33595345

Aim: To study the behavior of Candida albicans in women with vulvovaginal candidiasis (VVC), recurrent VVC (RVVC) and asymptomatic (AS), regarding adhesion on HeLa cells and their ability to express secreted aspartic proteinases (SAP) genes, agglutinin-like sequence (ALS) genes and HWP1. Materials & methods: The adhesion of Candida albicans to HeLa cells was evaluated by colony-forming units, and the expressed genes were evaluated by qRT-PCR. Results: AS and VVC isolates showed greater ability to adhere HeLa cells when compared with RVVC isolate. Nevertheless, RVVC isolate exhibited upregulation of a large number of genes of ALS and SAP gene families and HWP1 gene. Conclusion: The results demonstrated that RVVC isolate expressed significantly important genes for invasion and yeast-host interactions.


Aspartic Acid Proteases/metabolism , Candida albicans/genetics , Candidiasis, Vulvovaginal/microbiology , Aspartic Acid Proteases/genetics , Candida albicans/enzymology , Candida albicans/growth & development , Cervix Uteri/microbiology , Female , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , HeLa Cells , Humans
5.
Future Microbiol ; 15: 1249-1263, 2020 09.
Article En | MEDLINE | ID: mdl-33026881

Aim: To evaluate changes in virulence and pathogenicity approaches from Candida albicans after successive passages in a murine model of systemic candidiasis. Materials & methods: Phenotypic assays were performed using colonies recovered from animals infected serially, totalizing five passages. Results: A progressive infection was observed along the passages, with increased fungal burden and the presence of greater inflammatory areas in the histopathological findings. Recovered strains exhibited increased filamentation and biofilm abilities, along with modulation of phospholipase and proteinase activities. Conclusion: Repeated contact between yeast and host increased the expression of virulence factors. Furthermore, a correspondence between phenotypic profile and proteomic data obtained previously was observed.


Candida albicans/pathogenicity , Candidiasis/microbiology , Virulence Factors/metabolism , Animals , Biofilms/growth & development , Candida albicans/growth & development , Candida albicans/metabolism , Colony Count, Microbial , Cytokines/metabolism , Disease Models, Animal , Kidney/metabolism , Kidney/microbiology , Kidney/pathology , Mice , Peptide Hydrolases/metabolism , Phospholipases/metabolism
6.
Future Microbiol ; 15: 1001-1013, 2020 07.
Article En | MEDLINE | ID: mdl-32811174

Aim: To compare the pathogenesis of vulvovaginal candidiasis by three Candida species in diabetic mice. Materials & methods: Estrogenized and diabetic mice were challenged with C. albicans, C. tropicalis and C. glabrata. Results: Diabetic animals infected with C. albicans and C. tropicalis maintained the highest fungal burden, despite of high levels of proinflammatory cytokines (IL-6 and TNF-α), respectively. For C. glabrata, the results were similar in diabetic and nondiabetic groups. Conclusion:C. tropicalis was as invasive as C. albicans, and both were more effective than C. glabrata. This ability was attributed to filamentation, which may be stimulated by glucose levels from vaginal fluid. In addition, the high burden may be attributed to the apparent immunological inefficiency of the diabetic host.


Candida albicans/physiology , Candida glabrata/physiology , Candida tropicalis/physiology , Candidiasis, Vulvovaginal/microbiology , Diabetes Complications/microbiology , Animals , Candida albicans/genetics , Candida albicans/isolation & purification , Candida glabrata/genetics , Candida glabrata/isolation & purification , Candida tropicalis/genetics , Candida tropicalis/isolation & purification , Candidiasis, Vulvovaginal/etiology , Candidiasis, Vulvovaginal/genetics , Candidiasis, Vulvovaginal/metabolism , Diabetes Complications/etiology , Diabetes Complications/genetics , Diabetes Complications/metabolism , Disease Models, Animal , Female , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Mice , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
7.
Future Microbiol ; 14: 519-531, 2019 04.
Article En | MEDLINE | ID: mdl-31033353

Aim: To evaluate the efficacy of photodynamic inactivation (PDI) mediated by hypericin encapsulated in P-123 copolymeric micelles (P123-Hyp) alone and in combination with fluconazole (FLU) against planktonic cells and biofilm formation of Candida species Materials & methods: PDI was performed using P123-Hyp and an LED device with irradiance of 3.0 mW/cm2 . Results: Most of isolates (70%) were completely inhibited with concentrations up to 2.0 µmol/l of HYP and light fluence of 16.2 J/cm2. FLU-resistant strains had synergic effect with P123-HYP-PDI and FLU. The biofilm formation was inhibited in all species, in additional the changes in Candida morphology observed by scanning electron microscopy. Conclusion: P123-Hyp-PDI is a promising option to treat fungal infections and medical devices to prevent biofilm formation and fungal spread.


Antifungal Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Micelles , Perylene/analogs & derivatives , Anthracenes , Biofilms/growth & development , Biofilms/radiation effects , Candida/cytology , Candida/radiation effects , Drug Resistance, Fungal/drug effects , Drug Synergism , Drug Therapy, Combination , Fluconazole/pharmacology , Humans , Light , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Perylene/pharmacology , Photochemotherapy/methods
...